Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S. Fauci, MD, Director NIAID January 25-27, 2021

NEXT STORY
Valneva et l’Institut Butantan signent un accord final pour un vaccin à dose unique contre le chikungunya dans les pays à revenus faibles et intermédiaires
PREV STORY
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cancer Genetics, Inc. and Leading Collaborators to Present Innovative Insights That Will Advance Precision Medicine in Diffuse Large B-cell Lymphoma (DLBCL) at American Society of Hematology (ASH) Annual Meeting 2016

The two studies presented at ASH highlight new data on genomic and immune biomarkers, ...

author_avatar
NASDAQ Market News

Curis Announces CA-170 Poster Presentation at ESMO 2017 Congress

LEXINGTON, Mass., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News

ABLYNX COMMENCES DOSING IN ITS PHASE II STUDY OF ALX-0171 IN HOSPITALISED JAPANESE INFANTS WITH A RSV INFECTION

GHENT, Belgium, 2 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced ...

author_avatar
NASDAQ Market News